The global market for Pediatric Drugs and Vaccines was valued at US$ 113520 million in the year 2024 and is projected to reach a revised size of US$ 206320 million by 2031, growing at a CAGR of 9.0% during the forecast period.

Pediatric Drugs and Vaccines Market

Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child"s age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pediatric Drugs and Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Drugs and Vaccines.

The Pediatric Drugs and Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Drugs and Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pediatric Drugs and Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pediatric Drugs and Vaccines Market Report

Report Metric	Details
Report Name	Pediatric Drugs and Vaccines Market
Accounted market size in year	US$ 113520 million
Forecasted market size in 2031	US$ 206320 million
CAGR	9.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Diphtheria Influenza Hepatitis Pneumococcal Diseases Meningococcal Diseases Mumps Others
Segment by Application	Newborn Infant Child
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche Ltd (Switzerland), Genentech, Inc. (USA), GlaxoSmithKline plc. (UK), Janssen Biologics B.V. (USA), Actelion Pharmaceuticals, AstraZeneca Plc. (UK), Boehringer Ingelheim GmbH (Germany), Bristol-Myers Squibb Company (USA), Allergan, Inc. (USA), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Pfizer, Inc. (USA), Sanofi S.A (France), Shionogi Inc. (USA), Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pediatric Drugs and Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pediatric Drugs and Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pediatric Drugs and Vaccines Market growing?

Ans: The Pediatric Drugs and Vaccines Market witnessing a CAGR of 9.0% during the forecast period 2025-2031.

What is the Pediatric Drugs and Vaccines Market size in 2031?

Ans: The Pediatric Drugs and Vaccines Market size in 2031 will be US$ 206320 million.

Who are the main players in the Pediatric Drugs and Vaccines Market report?

Ans: The main players in the Pediatric Drugs and Vaccines Market are Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche Ltd (Switzerland), Genentech, Inc. (USA), GlaxoSmithKline plc. (UK), Janssen Biologics B.V. (USA), Actelion Pharmaceuticals, AstraZeneca Plc. (UK), Boehringer Ingelheim GmbH (Germany), Bristol-Myers Squibb Company (USA), Allergan, Inc. (USA), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Pfizer, Inc. (USA), Sanofi S.A (France), Shionogi Inc. (USA), Takeda

What are the Application segmentation covered in the Pediatric Drugs and Vaccines Market report?

Ans: The Applications covered in the Pediatric Drugs and Vaccines Market report are Newborn, Infant, Child

What are the Type segmentation covered in the Pediatric Drugs and Vaccines Market report?

Ans: The Types covered in the Pediatric Drugs and Vaccines Market report are Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, Mumps, Others

1 Pediatric Drugs and Vaccines Market Overview

1.1 Product Definition

1.2 Pediatric Drugs and Vaccines by Type

1.2.1 Global Pediatric Drugs and Vaccines Market Value Comparison by Type (2024 VS 2031)

1.2.2 Diphtheria

1.2.3 Influenza

1.2.4 Hepatitis

1.2.5 Pneumococcal Diseases

1.2.6 Meningococcal Diseases

1.2.7 Mumps

1.2.8 Others

1.3 Pediatric Drugs and Vaccines by Application

1.3.1 Global Pediatric Drugs and Vaccines Market Value by Application (2024 VS 2031)

1.3.2 Newborn

1.3.3 Infant

1.3.4 Child

1.4 Global Pediatric Drugs and Vaccines Market Size Estimates and Forecasts

1.4.1 Global Pediatric Drugs and Vaccines Revenue 2020-2031

1.4.2 Global Pediatric Drugs and Vaccines Sales 2020-2031

1.4.3 Global Pediatric Drugs and Vaccines Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Pediatric Drugs and Vaccines Market Competition by Manufacturers

2.1 Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pediatric Drugs and Vaccines Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pediatric Drugs and Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pediatric Drugs and Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pediatric Drugs and Vaccines, Product Type & Application

2.7 Global Key Manufacturers of Pediatric Drugs and Vaccines, Date of Enter into This Industry

2.8 Global Pediatric Drugs and Vaccines Market Competitive Situation and Trends

2.8.1 Global Pediatric Drugs and Vaccines Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pediatric Drugs and Vaccines Players Market Share by Revenue

2.8.3 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pediatric Drugs and Vaccines Market Scenario by Region

3.1 Global Pediatric Drugs and Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pediatric Drugs and Vaccines Sales by Region: 2020-2031

3.2.1 Global Pediatric Drugs and Vaccines Sales by Region: 2020-2025

3.2.2 Global Pediatric Drugs and Vaccines Sales by Region: 2026-2031

3.3 Global Pediatric Drugs and Vaccines Revenue by Region: 2020-2031

3.3.1 Global Pediatric Drugs and Vaccines Revenue by Region: 2020-2025

3.3.2 Global Pediatric Drugs and Vaccines Revenue by Region: 2026-2031

3.4 North America Pediatric Drugs and Vaccines Market Facts & Figures by Country

3.4.1 North America Pediatric Drugs and Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pediatric Drugs and Vaccines Sales by Country (2020-2031)

3.4.3 North America Pediatric Drugs and Vaccines Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pediatric Drugs and Vaccines Market Facts & Figures by Country

3.5.1 Europe Pediatric Drugs and Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pediatric Drugs and Vaccines Sales by Country (2020-2031)

3.5.3 Europe Pediatric Drugs and Vaccines Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pediatric Drugs and Vaccines Market Facts & Figures by Region

3.6.1 Asia Pacific Pediatric Drugs and Vaccines Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2020-2031)

3.6.3 Asia Pacific Pediatric Drugs and Vaccines Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pediatric Drugs and Vaccines Market Facts & Figures by Country

3.7.1 Latin America Pediatric Drugs and Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pediatric Drugs and Vaccines Sales by Country (2020-2031)

3.7.3 Latin America Pediatric Drugs and Vaccines Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pediatric Drugs and Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Pediatric Drugs and Vaccines Sales by Type (2020-2031)

4.1.1 Global Pediatric Drugs and Vaccines Sales by Type (2020-2025)

4.1.2 Global Pediatric Drugs and Vaccines Sales by Type (2026-2031)

4.1.3 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2020-2031)

4.2 Global Pediatric Drugs and Vaccines Revenue by Type (2020-2031)

4.2.1 Global Pediatric Drugs and Vaccines Revenue by Type (2020-2025)

4.2.2 Global Pediatric Drugs and Vaccines Revenue by Type (2026-2031)

4.2.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2020-2031)

4.3 Global Pediatric Drugs and Vaccines Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pediatric Drugs and Vaccines Sales by Application (2020-2031)

5.1.1 Global Pediatric Drugs and Vaccines Sales by Application (2020-2025)

5.1.2 Global Pediatric Drugs and Vaccines Sales by Application (2026-2031)

5.1.3 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2020-2031)

5.2 Global Pediatric Drugs and Vaccines Revenue by Application (2020-2031)

5.2.1 Global Pediatric Drugs and Vaccines Revenue by Application (2020-2025)

5.2.2 Global Pediatric Drugs and Vaccines Revenue by Application (2026-2031)

5.2.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2020-2031)

5.3 Global Pediatric Drugs and Vaccines Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck & Co., Inc. (USA)

6.1.1 Merck & Co., Inc. (USA) Company Information

6.1.2 Merck & Co., Inc. (USA) Description and Business Overview

6.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio

6.1.5 Merck & Co., Inc. (USA) Recent Developments/Updates

6.2 Abbott Laboratories (USA)

6.2.1 Abbott Laboratories (USA) Company Information

6.2.2 Abbott Laboratories (USA) Description and Business Overview

6.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolio

6.2.5 Abbott Laboratories (USA) Recent Developments/Updates

6.3 Amgen, Inc. (USA)

6.3.1 Amgen, Inc. (USA) Company Information

6.3.2 Amgen, Inc. (USA) Description and Business Overview

6.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio

6.3.5 Amgen, Inc. (USA) Recent Developments/Updates

6.4 Eli Lilly and Company (USA)

6.4.1 Eli Lilly and Company (USA) Company Information

6.4.2 Eli Lilly and Company (USA) Description and Business Overview

6.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolio

6.4.5 Eli Lilly and Company (USA) Recent Developments/Updates

6.5 F. Hoffmann-La Roche Ltd (Switzerland)

6.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Information

6.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview

6.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolio

6.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments/Updates

6.6 Genentech, Inc. (USA)

6.6.1 Genentech, Inc. (USA) Company Information

6.6.2 Genentech, Inc. (USA) Description and Business Overview

6.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio

6.6.5 Genentech, Inc. (USA) Recent Developments/Updates

6.7 GlaxoSmithKline plc. (UK)

6.7.1 GlaxoSmithKline plc. (UK) Company Information

6.7.2 GlaxoSmithKline plc. (UK) Description and Business Overview

6.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolio

6.7.5 GlaxoSmithKline plc. (UK) Recent Developments/Updates

6.8 Janssen Biologics B.V. (USA)

6.8.1 Janssen Biologics B.V. (USA) Company Information

6.8.2 Janssen Biologics B.V. (USA) Description and Business Overview

6.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolio

6.8.5 Janssen Biologics B.V. (USA) Recent Developments/Updates

6.9 Actelion Pharmaceuticals

6.9.1 Actelion Pharmaceuticals Company Information

6.9.2 Actelion Pharmaceuticals Description and Business Overview

6.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolio

6.9.5 Actelion Pharmaceuticals Recent Developments/Updates

6.10 AstraZeneca Plc. (UK)

6.10.1 AstraZeneca Plc. (UK) Company Information

6.10.2 AstraZeneca Plc. (UK) Description and Business Overview

6.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolio

6.10.5 AstraZeneca Plc. (UK) Recent Developments/Updates

6.11 Boehringer Ingelheim GmbH (Germany)

6.11.1 Boehringer Ingelheim GmbH (Germany) Company Information

6.11.2 Boehringer Ingelheim GmbH (Germany) Description and Business Overview

6.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolio

6.11.5 Boehringer Ingelheim GmbH (Germany) Recent Developments/Updates

6.12 Bristol-Myers Squibb Company (USA)

6.12.1 Bristol-Myers Squibb Company (USA) Company Information

6.12.2 Bristol-Myers Squibb Company (USA) Description and Business Overview

6.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolio

6.12.5 Bristol-Myers Squibb Company (USA) Recent Developments/Updates

6.13 Allergan, Inc. (USA)

6.13.1 Allergan, Inc. (USA) Company Information

6.13.2 Allergan, Inc. (USA) Description and Business Overview

6.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio

6.13.5 Allergan, Inc. (USA) Recent Developments/Updates

6.14 Novartis AG (Switzerland)

6.14.1 Novartis AG (Switzerland) Company Information

6.14.2 Novartis AG (Switzerland) Description and Business Overview

6.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolio

6.14.5 Novartis AG (Switzerland) Recent Developments/Updates

6.15 Novo Nordisk A/S (Denmark)

6.15.1 Novo Nordisk A/S (Denmark) Company Information

6.15.2 Novo Nordisk A/S (Denmark) Description and Business Overview

6.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolio

6.15.5 Novo Nordisk A/S (Denmark) Recent Developments/Updates

6.16 Pfizer, Inc. (USA)

6.16.1 Pfizer, Inc. (USA) Company Information

6.16.2 Pfizer, Inc. (USA) Description and Business Overview

6.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio

6.16.5 Pfizer, Inc. (USA) Recent Developments/Updates

6.17 Sanofi S.A (France)

6.17.1 Sanofi S.A (France) Company Information

6.17.2 Sanofi S.A (France) Description and Business Overview

6.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolio

6.17.5 Sanofi S.A (France) Recent Developments/Updates

6.18 Shionogi Inc. (USA)

6.18.1 Shionogi Inc. (USA) Company Information

6.18.2 Shionogi Inc. (USA) Description and Business Overview

6.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio

6.18.5 Shionogi Inc. (USA) Recent Developments/Updates

6.19 Takeda

6.19.1 Takeda Company Information

6.19.2 Takeda Description and Business Overview

6.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.19.4 Takeda Pediatric Drugs and Vaccines Product Portfolio

6.19.5 Takeda Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pediatric Drugs and Vaccines Industry Chain Analysis

7.2 Pediatric Drugs and Vaccines Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pediatric Drugs and Vaccines Production Mode & Process Analysis

7.4 Pediatric Drugs and Vaccines Sales and Marketing

7.4.1 Pediatric Drugs and Vaccines Sales Channels

7.4.2 Pediatric Drugs and Vaccines Distributors

7.5 Pediatric Drugs and Vaccines Customer Analysis

8 Pediatric Drugs and Vaccines Market Dynamics

8.1 Pediatric Drugs and Vaccines Industry Trends

8.2 Pediatric Drugs and Vaccines Market Drivers

8.3 Pediatric Drugs and Vaccines Market Challenges

8.4 Pediatric Drugs and Vaccines Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck & Co., Inc. (USA)

Abbott Laboratories(USA)

Amgen, Inc. (USA)

Eli Lilly and Company (USA)

F.Hoffmann-La Roche Ltd (Switzerland)

Genentech Inc. (USA)

GlaxoSmithKline Plc (UK)

Janssen Biologics B.V. (USA)

Actelion Pharmaceuticals

AstraZeneca Plc. (UK)

Boehringer Ingelheim GmbH (Germany)

Bristol-Myers Squibb Company (USA)

Allergan, Inc. (USA)

Novartis AG (Switzerland)

Novo Nordisk A/S (Denmark)

List of Tables

Table 1. Global Pediatric Drugs and Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pediatric Drugs and Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Pediatric Drugs and Vaccines Market Competitive Situation by Manufacturers in 2024

Table 4. Global Pediatric Drugs and Vaccines Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Pediatric Drugs and Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Pediatric Drugs and Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Pediatric Drugs and Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pediatric Drugs and Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pediatric Drugs and Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of Pediatric Drugs and Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pediatric Drugs and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Drugs and Vaccines as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pediatric Drugs and Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Pediatric Drugs and Vaccines Sales by Region (2020-2025) & (K Units)

Table 18. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2020-2025)

Table 19. Global Pediatric Drugs and Vaccines Sales by Region (2026-2031) & (K Units)

Table 20. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2026-2031)

Table 21. Global Pediatric Drugs and Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2020-2025)

Table 23. Global Pediatric Drugs and Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2026-2031)

Table 25. North America Pediatric Drugs and Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Pediatric Drugs and Vaccines Sales by Country (2020-2025) & (K Units)

Table 27. North America Pediatric Drugs and Vaccines Sales by Country (2026-2031) & (K Units)

Table 28. North America Pediatric Drugs and Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Pediatric Drugs and Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Pediatric Drugs and Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Pediatric Drugs and Vaccines Sales by Country (2020-2025) & (K Units)

Table 32. Europe Pediatric Drugs and Vaccines Sales by Country (2026-2031) & (K Units)

Table 33. Europe Pediatric Drugs and Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Pediatric Drugs and Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Pediatric Drugs and Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Pediatric Drugs and Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Pediatric Drugs and Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Pediatric Drugs and Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Pediatric Drugs and Vaccines Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Pediatric Drugs and Vaccines Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Pediatric Drugs and Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pediatric Drugs and Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Pediatric Drugs and Vaccines Sales (K Units) by Type (2020-2025)

Table 51. Global Pediatric Drugs and Vaccines Sales (K Units) by Type (2026-2031)

Table 52. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2020-2025)

Table 53. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2026-2031)

Table 54. Global Pediatric Drugs and Vaccines Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Pediatric Drugs and Vaccines Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2020-2025)

Table 57. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2026-2031)

Table 58. Global Pediatric Drugs and Vaccines Price (USD/Unit) by Type (2020-2025)

Table 59. Global Pediatric Drugs and Vaccines Price (USD/Unit) by Type (2026-2031)

Table 60. Global Pediatric Drugs and Vaccines Sales (K Units) by Application (2020-2025)

Table 61. Global Pediatric Drugs and Vaccines Sales (K Units) by Application (2026-2031)

Table 62. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2020-2025)

Table 63. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2026-2031)

Table 64. Global Pediatric Drugs and Vaccines Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Pediatric Drugs and Vaccines Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2020-2025)

Table 67. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2026-2031)

Table 68. Global Pediatric Drugs and Vaccines Price (USD/Unit) by Application (2020-2025)

Table 69. Global Pediatric Drugs and Vaccines Price (USD/Unit) by Application (2026-2031)

Table 70. Merck & Co., Inc. (USA) Company Information

Table 71. Merck & Co., Inc. (USA) Description and Business Overview

Table 72. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product

Table 74. Merck & Co., Inc. (USA) Recent Developments/Updates

Table 75. Abbott Laboratories (USA) Company Information

Table 76. Abbott Laboratories (USA) Description and Business Overview

Table 77. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product

Table 79. Abbott Laboratories (USA) Recent Developments/Updates

Table 80. Amgen, Inc. (USA) Company Information

Table 81. Amgen, Inc. (USA) Description and Business Overview

Table 82. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product

Table 84. Amgen, Inc. (USA) Recent Developments/Updates

Table 85. Eli Lilly and Company (USA) Company Information

Table 86. Eli Lilly and Company (USA) Description and Business Overview

Table 87. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product

Table 89. Eli Lilly and Company (USA) Recent Developments/Updates

Table 90. F. Hoffmann-La Roche Ltd (Switzerland) Company Information

Table 91. F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview

Table 92. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product

Table 94. F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments/Updates

Table 95. Genentech, Inc. (USA) Company Information

Table 96. Genentech, Inc. (USA) Description and Business Overview

Table 97. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product

Table 99. Genentech, Inc. (USA) Recent Developments/Updates

Table 100. GlaxoSmithKline plc. (UK) Company Information

Table 101. GlaxoSmithKline plc. (UK) Description and Business Overview

Table 102. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product

Table 104. GlaxoSmithKline plc. (UK) Recent Developments/Updates

Table 105. Janssen Biologics B.V. (USA) Company Information

Table 106. Janssen Biologics B.V. (USA) Description and Business Overview

Table 107. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product

Table 109. Janssen Biologics B.V. (USA) Recent Developments/Updates

Table 110. Actelion Pharmaceuticals Company Information

Table 111. Actelion Pharmaceuticals Description and Business Overview

Table 112. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product

Table 114. Actelion Pharmaceuticals Recent Developments/Updates

Table 115. AstraZeneca Plc. (UK) Company Information

Table 116. AstraZeneca Plc. (UK) Description and Business Overview

Table 117. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product

Table 119. AstraZeneca Plc. (UK) Recent Developments/Updates

Table 120. Boehringer Ingelheim GmbH (Germany) Company Information

Table 121. Boehringer Ingelheim GmbH (Germany) Description and Business Overview

Table 122. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product

Table 124. Boehringer Ingelheim GmbH (Germany) Recent Developments/Updates

Table 125. Bristol-Myers Squibb Company (USA) Company Information

Table 126. Bristol-Myers Squibb Company (USA) Description and Business Overview

Table 127. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product

Table 129. Bristol-Myers Squibb Company (USA) Recent Developments/Updates

Table 130. Allergan, Inc. (USA) Company Information

Table 131. Allergan, Inc. (USA) Description and Business Overview

Table 132. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product

Table 134. Allergan, Inc. (USA) Recent Developments/Updates

Table 135. Novartis AG (Switzerland) Company Information

Table 136. Novartis AG (Switzerland) Description and Business Overview

Table 137. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product

Table 139. Novartis AG (Switzerland) Recent Developments/Updates

Table 140. Novo Nordisk A/S (Denmark) Company Information

Table 141. Novo Nordisk A/S (Denmark) Description and Business Overview

Table 142. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product

Table 144. Novo Nordisk A/S (Denmark) Recent Developments/Updates

Table 145. Pfizer, Inc. (USA) Company Information

Table 146. Pfizer, Inc. (USA) Description and Business Overview

Table 147. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product

Table 149. Pfizer, Inc. (USA) Recent Developments/Updates

Table 150. Sanofi S.A (France) Company Information

Table 151. Sanofi S.A (France) Description and Business Overview

Table 152. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 153. Sanofi S.A (France) Pediatric Drugs and Vaccines Product

Table 154. Sanofi S.A (France) Recent Developments/Updates

Table 155. Shionogi Inc. (USA) Company Information

Table 156. Shionogi Inc. (USA) Description and Business Overview

Table 157. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 158. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product

Table 159. Shionogi Inc. (USA) Recent Developments/Updates

Table 160. Takeda Company Information

Table 161. Takeda Description and Business Overview

Table 162. Takeda Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 163. Takeda Pediatric Drugs and Vaccines Product

Table 164. Takeda Recent Developments/Updates

Table 165. Key Raw Materials Lists

Table 166. Raw Materials Key Suppliers Lists

Table 167. Pediatric Drugs and Vaccines Distributors List

Table 168. Pediatric Drugs and Vaccines Customers List

Table 169. Pediatric Drugs and Vaccines Market Trends

Table 170. Pediatric Drugs and Vaccines Market Drivers

Table 171. Pediatric Drugs and Vaccines Market Challenges

Table 172. Pediatric Drugs and Vaccines Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

Table 176. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pediatric Drugs and Vaccines

Figure 2. Global Pediatric Drugs and Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pediatric Drugs and Vaccines Market Share by Type: 2024 & 2031

Figure 4. Diphtheria Product Picture

Figure 5. Influenza Product Picture

Figure 6. Hepatitis Product Picture

Figure 7. Pneumococcal Diseases Product Picture

Figure 8. Meningococcal Diseases Product Picture

Figure 9. Mumps Product Picture

Figure 10. Others Product Picture

Figure 11. Global Pediatric Drugs and Vaccines Market Value by Application (2020-2031) & (US$ Million)

Figure 12. Global Pediatric Drugs and Vaccines Market Share by Application: 2024 & 2031

Figure 13. Newborn

Figure 14. Infant

Figure 15. Child

Figure 16. Global Pediatric Drugs and Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Pediatric Drugs and Vaccines Market Size (2020-2031) & (US$ Million)

Figure 18. Global Pediatric Drugs and Vaccines Sales (2020-2031) & (K Units)

Figure 19. Global Pediatric Drugs and Vaccines Average Price (USD/Unit) & (2020-2031)

Figure 20. Pediatric Drugs and Vaccines Report Years Considered

Figure 21. Pediatric Drugs and Vaccines Sales Share by Manufacturers in 2024

Figure 22. Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers in 2024

Figure 23. Global 5 and 10 Largest Pediatric Drugs and Vaccines Players: Market Share by Revenue in Pediatric Drugs and Vaccines in 2024

Figure 24. Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Global Pediatric Drugs and Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 26. North America Pediatric Drugs and Vaccines Sales Market Share by Country (2020-2031)

Figure 27. North America Pediatric Drugs and Vaccines Revenue Market Share by Country (2020-2031)

Figure 28. U.S. Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Canada Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Europe Pediatric Drugs and Vaccines Sales Market Share by Country (2020-2031)

Figure 31. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country (2020-2031)

Figure 32. Germany Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. France Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. U.K. Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Italy Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Russia Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Region (2020-2031)

Figure 38. Asia Pacific Pediatric Drugs and Vaccines Revenue Market Share by Region (2020-2031)

Figure 39. China Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Japan Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. South Korea Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. India Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Australia Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Taiwan Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Indonesia Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Thailand Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Malaysia Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Philippines Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Latin America Pediatric Drugs and Vaccines Sales Market Share by Country (2020-2031)

Figure 50. Latin America Pediatric Drugs and Vaccines Revenue Market Share by Country (2020-2031)

Figure 51. Mexico Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Brazil Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Argentina Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Country (2020-2031)

Figure 55. Middle East and Africa Pediatric Drugs and Vaccines Revenue Market Share by Country (2020-2031)

Figure 56. Turkey Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Saudi Arabia Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. U.A.E Pediatric Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Global Sales Market Share of Pediatric Drugs and Vaccines by Type (2020-2031)

Figure 60. Global Revenue Market Share of Pediatric Drugs and Vaccines by Type (2020-2031)

Figure 61. Global Pediatric Drugs and Vaccines Price (USD/Unit) by Type (2020-2031)

Figure 62. Global Sales Market Share of Pediatric Drugs and Vaccines by Application (2020-2031)

Figure 63. Global Revenue Market Share of Pediatric Drugs and Vaccines by Application (2020-2031)

Figure 64. Global Pediatric Drugs and Vaccines Price (USD/Unit) by Application (2020-2031)

Figure 65. Pediatric Drugs and Vaccines Value Chain

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32P14840

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20V18395

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32G20014

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9U20281

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions